USD
+$0.00
(+0.00%
)At Close (As of Nov 4, 2025)
$50.96M
Market Cap
-
P/E Ratio
-0.05
EPS
$9.33
52 Week High
$3.03
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $24M |
| Total Revenue | $42M |
| Cost Of Revenue | $17M |
| Costof Goods And Services Sold | $17M |
| Operating Income | $8.1M |
| Selling General And Administrative | $7.1M |
| Research And Development | $4.2M |
| Operating Expenses | $16M |
| Investment Income Net | - |
| Net Interest Income | $932K |
| Interest Income | $932K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $432K |
| Income Before Tax | $9M |
| Income Tax Expense | $2.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $6.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $8.1M |
| Ebitda | $8.5M |
| Net Income | $6.6M |
| Field | Value (USD) |
|---|---|
| Total Assets | $62M |
| Total Current Assets | $57M |
| Cash And Cash Equivalents At Carrying Value | $22M |
| Cash And Short Term Investments | $22M |
| Inventory | $10M |
| Current Net Receivables | $20M |
| Total Non Current Assets | $5.4M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $4.9M |
| Other Non Current Assets | - |
| Total Liabilities | $6.3M |
| Total Current Liabilities | $5.9M |
| Current Accounts Payable | $4.8M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $204K |
| Total Non Current Liabilities | $453K |
| Capital Lease Obligations | $602K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $602K |
| Other Current Liabilities | $329K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $56M |
| Treasury Stock | - |
| Retained Earnings | $13M |
| Common Stock | $169K |
| Common Stock Shares Outstanding | $16M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$831K |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $432K |
| Capital Expenditures | $276K |
| Change In Receivables | - |
| Change In Inventory | $268K |
| Profit Loss | - |
| Cashflow From Investment | -$276K |
| Cashflow From Financing | $15K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$52K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $6.6M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $24M |
| Total Revenue | $42M |
| Cost Of Revenue | $17M |
| Costof Goods And Services Sold | $17M |
| Operating Income | $8.1M |
| Selling General And Administrative | $7.1M |
| Research And Development | $4.2M |
| Operating Expenses | $16M |
| Investment Income Net | - |
| Net Interest Income | $932K |
| Interest Income | $932K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $432K |
| Income Before Tax | $9M |
| Income Tax Expense | $2.4M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $6.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $8.1M |
| Ebitda | $8.5M |
| Net Income | $6.6M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Sensus Healthcare, Inc. (SRTS) is a prominent innovator in the field of superficial radiation therapy, specializing in advanced treatment solutions for non-melanoma skin cancer and other conditions. Based in Boca Raton, Florida, the company leverages a well-established global distribution network to deliver its cutting-edge technology to healthcare providers worldwide. With a steadfast commitment to clinical excellence and continuous innovation, Sensus Healthcare is strategically enhancing its market position, aiming to meet the rising demand for effective, non-invasive treatment options within the dynamic healthcare environment.